CANC
Tema Oncology ETF
1 year +30.4%Every component of CANC and its weight in the fund, as of 2026-10-20.
| Component | Weight | % | Sector |
|---|---|---|---|
| RVMDRevolution Medicines Inc · United States | 5.44% | Healthcare | |
| MRKMerck & Company Inc · United States | 5.23% | Healthcare | |
| LLYEli Lilly and Company · United States | 5.14% | Healthcare | |
| UMRXCogent Biosciences Inc · United States | 4.65% | Healthcare | |
| NOVNNovartis AG · Switzerland | 4.24% | Healthcare | |
| GMABGenmab AS · United States | 3.80% | Healthcare | |
| BGNEBeiGene Ltd · United States | 3.73% | Healthcare | |
| HALOHalozyme Therapeutics Inc · United States | 3.71% | Healthcare | |
| EXELExelixis Inc · United States | 3.60% | Healthcare | |
| IOVAIovance Biotherapeutics Inc · United States | 3.46% | Healthcare | |
| ABBVAbbVie Inc · United States | 3.32% | Healthcare | |
| RHHBYRoche Holding Ltd ADR · United States | 2.87% | Healthcare | |
| BBIOBridgeBio Pharma Inc · United States | 2.77% | Healthcare | |
| BMYBristol-Myers Squibb Company · United States | 2.60% | Healthcare | |
| IDYAIdeaya Biosciences Inc · United States | 2.45% | Healthcare | |
| CGONCG Oncology, Inc. Common stock · United States | 2.40% | Healthcare | |
| IMNMImmunome Inc · United States | 2.24% | Healthcare | |
| AZNAstraZeneca PLC · United Kingdom | 2.22% | Healthcare | |
| ELVNEnliven Therapeutics Inc. · United States | 2.17% | Healthcare | |
| JNJJohnson & Johnson · United States | 2.05% | Healthcare | |
| LEGNLegend Biotech Corp · United States | 2.05% | Healthcare | |
| ERASErasca Inc · United States | 1.99% | Healthcare | |
| RLAYRelay Therapeutics Inc · United States | 1.89% | Healthcare | |
| ZLABZai Lab Ltd · United States | 1.76% | Healthcare | |
| SMMTSummit Therapeutics PLC · United States | 1.61% | Healthcare | |
| FXFXXFirst American Funds Inc. - Treasury Obligations Fund · United States | 1.59% | ||
| AMGNAmgen Inc · United States | 1.37% | Healthcare | |
| CELCCelcuity LLC · United States | 1.36% | Healthcare | |
| ZA8ZYMEWORKS DL-00001 · Germany | 1.32% | Healthcare | |
| NTRANatera Inc · United States | 1.31% | Healthcare | |
| NKNantKwest Inc · United States | 1.07% | Healthcare | |
| GILDGilead Sciences Inc · United States | 1.06% | Healthcare | |
| NUVBNuvation Bio Inc · United States | 1.03% | Healthcare | |
| KURAKura Oncology Inc · United States | 1.02% | Healthcare | |
| URGNUroGen Pharma Ltd · United States | 1.01% | Healthcare | |
| RCUSArcus Biosciences Inc · United States | 0.99% | Healthcare | |
| CRVSCorvus Pharmaceuticals Inc · United States | 0.75% | Healthcare | |
| GHGuardant Health Inc · United States | 0.75% | Healthcare | |
| ORICOric Pharmaceuticals Inc · United States | 0.72% | Healthcare | |
| IMCRImmunocore Holdings Ltd · United States | 0.69% | Healthcare | |
| BCTGBCTG Acquisition Corp · United States | 0.66% | Financial Services | |
| REPLReplimune Group Inc · United States | 0.64% | Healthcare | |
| ANLAdlai Nortye Ltd. American Depositary Shares · United States | 0.63% | Healthcare | |
| INBXInhibrx Biosciences, Inc. · United States | 0.63% | Healthcare | |
| VSTMVerastem Inc · United States | 0.57% | Healthcare | |
| MRNAModerna Inc · United States | 0.50% | Healthcare | |
| IMTXImmatics NV · United States | 0.49% | Healthcare | |
| JANXJanux Therapeutics Inc · United States | 0.48% | Healthcare | |
| ANABAnaptysBio Inc · United States | 0.47% | Healthcare | |
| CGEMCullinan Oncology LLC · United States | 0.42% | Healthcare | |
| CADLCandel Therapeutics Inc · United States | 0.41% | Healthcare | |
| BCAXBicara Therapeutics Inc. Common Stock · United States | 0.35% | Healthcare | |
| AVBPArriVent BioPharma, Inc. Common Stock · United States | 0.31% | Healthcare | |
| CTMXCytomX Therapeutics Inc · United States | 0.30% | Healthcare | |
| OLMAOlema Pharmaceuticals Inc · United States | 0.29% | Healthcare | |
| TYRA_OLDTYRA · United States | 0.27% | Healthcare | |
| AUTLAutolus Therapeutics Ltd · United States | 0.23% | Healthcare | |
| ARVNArvinas Inc · United States | 0.21% | Healthcare |
From the market data provider's fund data, read 2026-10-20. Returns are the fund's own; past returns say nothing certain about future ones. None of this is advice.